C-reactive protein in relation to the development of microalbuminuria in type 1 diabetes - The Oxford Regional Prospective Study

被引:21
作者
Marcovecchio, M. Loredana [1 ,2 ]
Giannini, Cosimo [2 ]
Widmer, Barry [1 ]
Dalton, R. Neil [3 ]
Martinotti, Stefano [4 ]
Chiarelli, Francesco [2 ]
Dunger, David B. [1 ]
机构
[1] Addenbrookes Hosp, Univ Dept Paediat, Cambridge CB2 2QQ, England
[2] Univ Dept Paediat, Chieti, Italy
[3] Evelina Childrens Hosp, WellChild Lab, London, England
[4] Dept Pathol, Chieti, Italy
关键词
D O I
10.2337/dc07-2101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES - To perform a longitudinal evaluation of high-sensitivity C-reactive protein (hs-CRP) in young people with type I diabetes in relation to the development of microalbuminuria (MA). RESEARCH DESIGN AND METHODS - hs-CRP was measured in 329 blood samples collected from 49 subjects with type I diabetes with MA and 49 normoalbuminuric subjects matched for age, sex, and duration of diabetes. RESULTS - In subjects developing MA, a progressive rise in hs-CRP was detected with levels significantly higher in the years after the onset of MA when compared with levels before MA onset (P = 0.003; age-adjusted P = 0.06). After the onset of MA, hs-CRP levels were significantly higher in subjects with MA when compared with normoalbuminuric subjects (median 1.9 mg/l [range 0.2-9.8] vs. 1.1 mg/l [0.2-6.4]; P = 0.02; adjusted P = 0.036). CONCLUSIONS - In this population of young subjects with type 1 diabetes, there was a significant increase in hs-CRP levels after the onset of MA, likely reflecting a general state of inflammation.
引用
收藏
页码:974 / 976
页数:3
相关论文
共 12 条
[1]   Association of low-grade inflammation with nephropathy in type 2 diabetic patients: Role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines [J].
Abrahamian, H. ;
Endler, G. ;
Exner, M. ;
Mauler, H. ;
Raith, M. ;
Endler, L. ;
Rumpold, H. ;
Gerdov, M. ;
Mannhalter, C. ;
Prager, R. ;
Irsigler, K. ;
Wagner, O. F. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (01) :38-41
[2]  
Feldt-Rasmussen B, 2000, DIABETES METAB, V26, P64
[3]   C-reactive protein concentration and cardiovascular disease risk factors in children - Findings from the National Health and Nutrition Examination Survey 1999-2000 [J].
Ford, ES .
CIRCULATION, 2003, 108 (09) :1053-1058
[4]   C-reactive protein concentration distribution among US children and young adults: Findings from the National Health and Nutrition Examination Survey, 1999-2000 [J].
Ford, ES ;
Giles, WH ;
Myers, GL ;
Rifai, N ;
Ridker, PM ;
Mannino, DM .
CLINICAL CHEMISTRY, 2003, 49 (08) :1353-1357
[5]   Elevated C-reactive protein associates with early-stage carotid atherosclerosisis in young subjects with type 1 diabetes [J].
Hayaishi-Okano, R ;
Yamasaki, Y ;
Katakami, N ;
Ohtoshi, K ;
Gorogawa, S ;
Kuroda, A ;
Matsuhisa, M ;
Kosugi, K ;
Nishikawa, N ;
Kajimoto, Y ;
Hori, M .
DIABETES CARE, 2002, 25 (08) :1432-1438
[6]   C-reactive protein: Risk marker or mediator in atherothrombosis? [J].
Jialal, I ;
Devaraj, S ;
Venugopal, SK .
HYPERTENSION, 2004, 44 (01) :6-11
[7]   Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy [J].
Myrup, B ;
deMaat, M ;
Rossing, P ;
Gram, J ;
Kluft, C ;
Jespersen, J .
THROMBOSIS RESEARCH, 1996, 81 (04) :485-490
[8]   Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients [J].
Saraheimo, M ;
Teppo, AM ;
Forsblom, C ;
Fagerudd, J ;
Groop, PH .
DIABETOLOGIA, 2003, 46 (10) :1402-1407
[9]   Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction:: evidence for chronic inflammation [J].
Schalkwijk, CG ;
Poland, DCW ;
van Dijk, W ;
Kok, A ;
Emeis, JJ ;
Dräger, AM ;
Doni, A ;
van Hinsbergh, VWM ;
Stehouwer, CDA .
DIABETOLOGIA, 1999, 42 (03) :351-357
[10]   Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes - The EURODIAB prospective complications study [J].
Schram, MT ;
Chaturvedi, N ;
Schalkwijk, C ;
Giorgino, F ;
Ebeling, P ;
Fuller, JH ;
Stehouwer, CD .
DIABETES CARE, 2003, 26 (07) :2165-2173